Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C.

Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.

PMID:
30120041
2.

Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.

Reuzé S, Schernberg A, Orlhac F, Sun R, Chargari C, Dercle L, Deutsch E, Buvat I, Robert C.

Int J Radiat Oncol Biol Phys. 2018 May 22. pii: S0360-3016(18)30815-0. doi: 10.1016/j.ijrobp.2018.05.022. [Epub ahead of print]

PMID:
30064704
3.

Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma.

Manson G, Herbaux C, Brice P, Bouabdallah K, Stamatoullas A, Schiano JM, Ghesquieres H, Dercle L, Houot R; Lymphoma Study Association.

Blood. 2018 Jun 21;131(25):2856-2859. doi: 10.1182/blood-2018-03-841262. Epub 2018 May 3. No abstract available.

PMID:
29724901
4.

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

Mekki A, Dercle L, Lichtenstein P, Marabelle A, Michot JM, Lambotte O, Le Pavec J, De Martin E, Balleyguier C, Champiat S, Ammari S.

Eur J Cancer. 2018 Jun;96:91-104. doi: 10.1016/j.ejca.2018.03.006. Epub 2018 Apr 23.

PMID:
29698933
5.

Study of a seventeenth-century French artificial mummy: autopsical, native, and contrast-injected CT investigations.

Colleter R, Dedouit F, Duchesne S, Gérard P, Dercle L, Poilpré P, Gendrot V, Rousseau H, Crubézy É, Telmon N, Mokrane FZ.

Int J Legal Med. 2018 Sep;132(5):1405-1413. doi: 10.1007/s00414-018-1830-8. Epub 2018 Mar 28.

PMID:
29594348
6.

Complete Metabolic Response of Advanced Melanoma to Vemurafenib Assessed with FDG-PET-CT at 85 Hours.

Pascal P, Dercle L, Weyts K, Meyer N, Courbon F.

Clin Nucl Med. 2018 May;43(5):333-334. doi: 10.1097/RLU.0000000000002032.

PMID:
29485438
7.

Towards multi-phase postmortem CT angiography in children: a study on a porcine model.

Mokrane FZ, Dercle L, Meyrignac O, Crubézy É, Rousseau H, Telmon N, Dedouit F.

Int J Legal Med. 2018 Sep;132(5):1391-1403. doi: 10.1007/s00414-018-1783-y. Epub 2018 Jan 30.

PMID:
29380125
8.

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

Dercle L, Ammari S, Seban RD, Schwartz LH, Houot R, Labaied N, Mokrane FZ, Lazarovici J, Danu A, Marabelle A, Ribrag V, Michot JM.

Eur J Cancer. 2018 Mar;91:136-144. doi: 10.1016/j.ejca.2017.12.015.

PMID:
29360605
9.

[Hodgkin lymphoma: Current and future therapeutic strategies].

Turpin A, Michot JM, Kempf E, Mazeron R, Dartigues P, Terroir M, Boros A, Bonnetier S, Castilla-Llorente C, Coman T, Danu A, Ghez D, Pilorge S, Arfi-Rouche J, Dercle L, Soria JC, Carde P, Ribrag V, Fermé C, Lazarovici J.

Bull Cancer. 2018 Jan;105(1):81-98. doi: 10.1016/j.bulcan.2017.11.008. Epub 2017 Dec 27. Review. French.

PMID:
29289336
10.

The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.

Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH.

Abdom Radiol (NY). 2018 Feb;43(2):415-434. doi: 10.1007/s00261-017-1374-2.

PMID:
29143875
11.

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

Aspeslagh S, Matias M, Palomar V, Dercle L, Lanoy E, Soria JC, Postel-Vinay S.

Eur J Cancer. 2017 Dec;87:65-74. doi: 10.1016/j.ejca.2017.09.027. Epub 2017 Nov 7.

PMID:
29126088
12.

Interobserver variability in tumor contouring affects the use of radiomics to predict mutational status.

Huang Q, Lu L, Dercle L, Lichtenstein P, Li Y, Yin Q, Zong M, Schwartz L, Zhao B.

J Med Imaging (Bellingham). 2018 Jan;5(1):011005. doi: 10.1117/1.JMI.5.1.011005. Epub 2017 Oct 20.

PMID:
29098170
13.

Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.

Dercle L, Hartl D, Rozenblum-Beddok L, Mokrane FZ, Seban RD, Yeh R, Bidault F, Ammari S.

Eur Radiol. 2018 Apr;28(4):1761-1770. doi: 10.1007/s00330-017-5063-x. Epub 2017 Oct 30.

PMID:
29086023
14.

A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.

Schernberg A, Reuze S, Orlhac F, Buvat I, Dercle L, Sun R, Limkin E, Escande A, Haie-Meder C, Deutsch E, Chargari C, Robert C.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):187-195. doi: 10.1007/s00259-017-3824-z. Epub 2017 Sep 15.

PMID:
28916879
15.

[Computational medical imaging (radiomics) and potential for immuno-oncology].

Sun R, Limkin EJ, Dercle L, Reuzé S, Zacharaki EI, Chargari C, Schernberg A, Dirand AS, Alexis A, Paragios N, Deutsch É, Ferté C, Robert C.

Cancer Radiother. 2017 Oct;21(6-7):648-654. doi: 10.1016/j.canrad.2017.07.035. Epub 2017 Aug 31. Review. French.

PMID:
28865968
16.

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).

Sun R, Champiat S, Dercle L, Aspeslagh S, Castanon E, Limkin EJ, Baldini C, Postel-Vinay S, Hollebecque A, Massard C, Ammari S, Deutsch E, Soria JC, Marabelle A, Ferté C.

Eur J Cancer. 2017 Oct;84:202-211. doi: 10.1016/j.ejca.2017.07.033. Epub 2017 Aug 18.

PMID:
28826073
17.

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence.

Dercle L, Ammari S, Bateson M, Durand PB, Haspinger E, Massard C, Jaudet C, Varga A, Deutsch E, Soria JC, Ferté C.

Sci Rep. 2017 Aug 11;7(1):7952. doi: 10.1038/s41598-017-08310-5.

18.

18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

Dercle L, Seban RD, Lazarovici J, Schwartz LH, Houot R, Ammari S, Danu A, Edeline V, Marabelle A, Ribrag V, Michot JM.

J Nucl Med. 2018 Jan;59(1):15-24. doi: 10.2967/jnumed.117.193011. Epub 2017 Jun 8.

19.

Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.

Reuzé S, Orlhac F, Chargari C, Nioche C, Limkin E, Riet F, Escande A, Haie-Meder C, Dercle L, Gouy S, Buvat I, Deutsch E, Robert C.

Oncotarget. 2017 Jun 27;8(26):43169-43179. doi: 10.18632/oncotarget.17856.

20.

Evaluation of 2 diuretic 18Fluorine-Fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intra-pelvic cancer.

Dierickx LO, Dercle L, Chaltiel L, Caselles O, Brillouet S, Zerdoud S, Courbon F.

Q J Nucl Med Mol Imaging. 2017 Mar 29. doi: 10.23736/S1824-4785.17.02912-0. [Epub ahead of print]

PMID:
28358186
21.

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.

Limkin EJ, Sun R, Dercle L, Zacharaki EI, Robert C, Reuzé S, Schernberg A, Paragios N, Deutsch E, Ferté C.

Ann Oncol. 2017 Jun 1;28(6):1191-1206. doi: 10.1093/annonc/mdx034. Review.

PMID:
28168275
22.

Technical note: A preliminary comparative study between classical and interventional radiological approaches for multi-phase post-mortem CT angiography.

Mokrane FZ, Savall F, Dercle L, Crubezy E, Telmon N, Rousseau H, Dedouit F.

Forensic Sci Int. 2017 Feb;271:23-32. doi: 10.1016/j.forsciint.2016.12.008. Epub 2016 Dec 19.

PMID:
28056376
23.

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

Champiat S, Dercle L, Ammari S, Massard C, Hollebecque A, Postel-Vinay S, Chaput N, Eggermont A, Marabelle A, Soria JC, Ferté C.

Clin Cancer Res. 2017 Apr 15;23(8):1920-1928. doi: 10.1158/1078-0432.CCR-16-1741. Epub 2016 Nov 8.

24.

The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.

Terroir M, Borget I, Bidault F, Ricard M, Deschamps F, Hartl D, Tselikas L, Dercle L, Lumbroso J, Baudin E, Berdelou A, Deandreis D, Schlumberger M, Leboulleux S.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):638-646. doi: 10.1007/s00259-016-3551-x. Epub 2016 Oct 29.

PMID:
27796544
25.

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.

Michot JM, Mazeron R, Dercle L, Ammari S, Canova C, Marabelle A, Rose S, Rubin E, Deutsch E, Soria JC, Ribrag V, Levy A.

Eur J Cancer. 2016 Oct;66:91-4. doi: 10.1016/j.ejca.2016.06.017. Epub 2016 Aug 18. No abstract available.

PMID:
27544928
26.

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

Dercle L, Ammari S, Champiat S, Massard C, Ferté C, Taihi L, Seban RD, Aspeslagh S, Mahjoubi L, Kamsu-Kom N, Robert C, Marabelle A, Schlumberger M, Soria JC, Postel-Vinay S.

Eur J Cancer. 2016 Sep;65:33-42. doi: 10.1016/j.ejca.2016.05.031. Epub 2016 Jul 21.

PMID:
27451022
27.

Evaluation of (124)I PET/CT and (124)I PET/MRI in the management of patients with differentiated thyroid cancer.

Dercle L, Deandreis D, Terroir M, Leboulleux S, Lumbroso J, Schlumberger M.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1006-10. doi: 10.1007/s00259-016-3334-4. No abstract available.

PMID:
26928579
28.

Gated blood pool SPECT: The estimation of right ventricular volume and function is algorithm dependent in a clinical setting.

Dercle L, Ouali M, Pascal P, Giraudmaillet T, Chisin R, Lairez O, Marachet MA, Rousseau H, Bastié D, Bouallègue FB, Berry I.

J Nucl Cardiol. 2015 Jun;22(3):483-92. doi: 10.1007/s12350-014-0062-7. Epub 2015 Feb 20.

PMID:
25698473
29.

Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Dercle L, Chisin R, Ammari S, Gillebert Q, Ouali M, Jaudet C, Delord JP, Dierickx L, Zerdoud S, Schlumberger M, Courbon F.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):397-408. doi: 10.1007/s00259-014-2938-9. Epub 2014 Nov 1.

PMID:
25367748
30.

Is TOMPOOL (gated blood-pool SPECT processing software) accurate to diagnose right and left ventricular dysfunction in a clinical setting?

Dercle L, Giraudmaillet T, Pascal P, Lairez O, Chisin R, Marachet MA, Ouali M, Rousseau H, Bastié D, Berry I.

J Nucl Cardiol. 2014 Oct;21(5):1011-22. doi: 10.1007/s12350-014-9915-3. Epub 2014 May 30.

PMID:
24875579
31.

Prediction of all-cause mortality from gated-SPECT global myocardial wall thickening: comparison with ejection fraction and global longitudinal 2D-strain.

Lairez O, Cognet T, Dercle L, Méjean S, Berry M, Bastié D, Richaud R, Gautier M, Fouilloux A, Galinier M, Carrié D, Massabuau P, Berry I.

J Nucl Cardiol. 2014 Feb;21(1):86-95. doi: 10.1007/s12350-013-9813-0. Epub 2013 Oct 30.

PMID:
24170624
32.

New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value.

Cognet T, Vervueren PL, Dercle L, Bastié D, Richaud R, Berry M, Marchal P, Gautier M, Fouilloux A, Galinier M, Carrié D, Massabuau P, Berry I, Lairez O.

Cardiovasc Diabetol. 2013 Jun 7;12:84. doi: 10.1186/1475-2840-12-84.

Supplemental Content

Loading ...
Support Center